LPCN News and Press, Lipocine Inc. From 11/06/20

Lipocine Provides Regulatory Update on TLANDO™ PR Newswire SALT LAKE CITY, Nov. 6, 2020 SALT LAKE CITY , Nov. 6, 2020 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders,...

Lipocine to Present Preclinical Data on Therapeutic Potential of LPCN 1144 in Hepatic Fibrosis and NASH at The Liver Meeting Digital Experience™ PR Newswire SALT LAKE CITY, Nov. 5, 2020 SALT LAKE CITY , Nov. 5, 2020 /PRNewswire/ -- Lipocine Inc. (...

Biotech Penny Stocks On Robinhood Catching Attention This Week One of the fastest-growing platforms for buying penny stocks right now is Robinhood. I’m no advocate for the mobile broker. But there is something to be said about the design of the user interface that has made it...

Lipocine Announces Presentations at the 21st Annual Fall Meeting of the Sexual Medicine Society of North America -- Is Oral Testosterone a Potential Treatment for COVID-19 in Men? -- TLANDO™, Oral Testosterone Replacement Therapy Without Dose Titration Requirement ...

These Penny Stocks Are Turning Heads In October & 2020 In General We can finally say that October is off to a running start and penny stocks are leading the charge. More specifically speaking, small cap stocks are gaining a lot of interest. I’m not just saying that be...

Lipocine to Present at the H.C. Wainwright 4th Annual NASH Investor Conference PR Newswire SALT LAKE CITY, Sept. 29, 2020 SALT LAKE CITY , Sept. 29, 2020 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a clinical-stage biopharmaceutical company focused on ...

Should These Biotech Penny Stocks Be On Your List Right Now? Biotech penny stocks are some of the most sought after in the stock market today. It isn’t because they’re leading the market. For the most part, investors look to these penny stocks for their future potentia...

Are These Pre Market Movers On Your Penny Stocks List Today? Looking for top penny stocks and some premarket movers today? Some platforms may limit your access to trading during premarket. However, there are ways to at least look at the stock market before the opening bell. In many ...

Lipocine (LPCN) -1.2% announced that the last patient has been enrolled in its LiFT Phase 2 clinical study.LPCN 1144, an oral prodrug of endogenous testosterone has shown meaningful reductions of liver fat in our proof of concept liver fat imaging study in hypogonadal males and has ...

Lipocine Announces Completion of Enrollment in the LPCN 1144 LiFT Study Phase 2 Clinical Study Investigating LPCN 1144 in Biopsy-Confirmed Non-Cirrhotic NASH Subjects PR Newswire SALT LAKE CITY, Sept. 21, 2020 SALT LAKE CITY , Sept. 21, 2020 /PRNewswire/ ...